Return to PJ Online Home Page
The Pharmaceutical Journal Vol 265 No 7115 p436
September 23, 2000 News

Society empowered to authorise under-cover surveillance

The Royal Pharmaceutical Society’s director of professional standards (Mrs Susan Sharpe) and head of pharmacy law (Mr Stephen Lutener) will soon be allowed to authorise directed covert surveillance under the Regulation of Investigatory Powers Act 2000.
An Order to give them this authority comes into effect on September 25.
The Act, which came into force in July, sets down a legal framework for the interception of communications, surveillance in the course of authorised investigations and related matters. The Society is included in a list of public authorities which are allowed to authorise directed surveillance as part of investigations to detect or prevent crime, or in the interests of public safety or public health, among other purposes.
Under the Act, directed surveillance is defined as covert surveillance which does not entail the presence of individuals or use of monitoring devices on residential premises or in private vehicles. The surveillance must also be proportionate and be carried out for the purposes of a specific investigation. Authorisations have to given in writing, other than in urgent cases, and must specify the nature of the surveillance, the circumstances in which it is to be carried out and the nature of the investigation being undertaken. Oral authorisations expire after 72 hours, unless renewed; written authorisations are valid for three months, unless renewed.
Authorisation is necessary for investigations which might lead to either criminal action or Statutory Committee proceedings.
Mr Lutener told The Journal on September 19 that the Act did not affect the existing activities of the Society other than to lay down a legal framework for certain aspects of its investigatory operations.
“If provision had not been made for the Society to undertake such surveillance, it would have been unable to use covert directed surveillance to collect evidence for its proceedings. We would have had to bring in the police or Medicines Control Agency to do it for us.”
He added that directed covert surveillance was rarely used, having been necessary in only one case dealt with by the courts in the past year.